Literature DB >> 15769742

Attribution of the various inhibitory actions of the streptococcal inhibitor of complement (SIC) to regions within the molecule.

Michael J Binks1, Barbara A Fernie-King, David J Seilly, Peter J Lachmann, Kadaba S Sriprakash.   

Abstract

Some strains of Streptococcus pyogenes secrete a virulence factor called the streptococcal inhibitor of complement (SIC) function. SIC is a polyfunctional protein that interacts with a number of host proteins and peptides, especially with those that are involved in host defense systems. In addition to inhibiting the complement-mediated lysis of cells, SIC inhibits lysozyme, secretory leukocyte proteinase inhibitor, and beta-defensins. SIC also binds to proteins associated with the cytoskeleton and thereby may cause cytoskeletal derangement. The SIC molecule has three distinct structural domains constituting the N-proximal short repeat region (SRR), the central long repeat region (LRR), and the C-proximal proline-rich region (PRR). To map various functions to the structural domains, we have analyzed recombinant subclones expressing various parts of SIC and elastase-generated discrete fragments of SIC for binding to various ligands and for determining their biological properties. The results demonstrate the following. (a) SRR alone was sufficient to confer inhibition of complement function. (b) Anti-defensin and anti-lysozyme activities were mapped to the SRR plus LRR. (c) The LRR plus PRR harbored ezrin binding activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15769742     DOI: 10.1074/jbc.M414194200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Genetic characterization and virulence role of the RALP3/LSA locus upstream of the streptolysin s operon in invasive M1T1 Group A Streptococcus.

Authors:  Laura A Kwinn; Arya Khosravi; Ramy K Aziz; Anjuli M Timmer; Kelly S Doran; Malak Kotb; Victor Nizet
Journal:  J Bacteriol       Date:  2006-11-17       Impact factor: 3.490

2.  DRS is far less divergent than streptococcal inhibitor of complement of group A streptococcus.

Authors:  Vivek Sagar; Rajesh Kumar; Nirmal K Ganguly; Thangam Menon; Anuradha Chakraborti
Journal:  J Bacteriol       Date:  2007-01-19       Impact factor: 3.490

3.  The 4.5S RNA component of the signal recognition particle is required for group A Streptococcus virulence.

Authors:  Jeanette Treviño; Nataly Perez; Paul Sumby
Journal:  Microbiology (Reading)       Date:  2010-01-28       Impact factor: 2.777

4.  Seropositivity for Antibodies to DRS-G, a Virulence Factor from Streptococcus dysgalactiae subsp. equisimilis, Is an Independent Risk Factor for Poststreptococcus Glomerulonephritis and Chronic Kidney Disease in Mumbai, India.

Authors:  Gouri P Hule; Mohan G Karmarkar; Ainslie Cameron; Niwrutti Hase; Uday Khopkar; Preeti R Mehta; Celia L McNeilly; David McMillan; Kadaba S Sriprakash
Journal:  Clin Vaccine Immunol       Date:  2015-06-17

5.  The extracytoplasmic function sigma factor SigV plays a key role in the original model of lysozyme resistance and virulence of Enterococcus faecalis.

Authors:  André Le Jeune; Riccardo Torelli; Maurizio Sanguinetti; Jean-Christophe Giard; Axel Hartke; Yanick Auffray; Abdellah Benachour
Journal:  PLoS One       Date:  2010-03-11       Impact factor: 3.240

6.  The lysozyme-induced peptidoglycan N-acetylglucosamine deacetylase PgdA (EF1843) is required for Enterococcus faecalis virulence.

Authors:  Abdellah Benachour; Rabia Ladjouzi; André Le Jeune; Laurent Hébert; Simon Thorpe; Pascal Courtin; Marie-Pierre Chapot-Chartier; Tomasz K Prajsnar; Simon J Foster; Stéphane Mesnage
Journal:  J Bacteriol       Date:  2012-09-07       Impact factor: 3.490

7.  Seroreactivity against streptococcal DRS (distantly related to SIC) protein is a predictor for end-stage renal failure.

Authors:  Virginia A F Boon; James L Munro; George W Kan; James Burnell; Richard Speare
Journal:  Clin Vaccine Immunol       Date:  2008-08-06

8.  Enterococcus faecalis constitutes an unusual bacterial model in lysozyme resistance.

Authors:  Laurent Hébert; Pascal Courtin; Riccardo Torelli; Maurizio Sanguinetti; Marie-Pierre Chapot-Chartier; Yanick Auffray; Abdellah Benachour
Journal:  Infect Immun       Date:  2007-09-04       Impact factor: 3.441

9.  DrsG from Streptococcus dysgalactiae subsp. equisimilis inhibits the antimicrobial peptide LL-37.

Authors:  Danielle Smyth; Ainslie Cameron; Mark R Davies; Celia McNeilly; Louise Hafner; Kadaba S Sriprakash; David J McMillan
Journal:  Infect Immun       Date:  2014-03-24       Impact factor: 3.441

10.  Seroprevalence of Streptococcal Inhibitor of Complement (SIC) suggests association of streptococcal infection with chronic kidney disease.

Authors:  Mohan Ganesh Karmarkar; Gouri Pandharinath Hule; Niwrutti Khandu Hase; Preeti Rajeev Mehta; Scott Robert Walter; Kadaba Srinivasa Sriprakash
Journal:  BMC Nephrol       Date:  2013-05-06       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.